Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Evidence exists that oxidative stress is enhanced in congestive heart failure patients resulting in damage to cellular lipids, proteins and DNA. Because of free radical-induced apoptosis of skeletal muscle fibers, oxidative stress is an important contributor to skeletal muscle fatigue and low exercise tolerance of congestive heart failure patients. Enhanced oxidative stress in congestive heart failure can exert negative inotropic effects and can have important effects on the structure and function of the myocardium, and may be implicated in the progression of congestive heart failure. Free radical stress could also impair recruitment and differentiation of circulating endothelial progenitor cells resulting in increased all cause mortality.
Reduced pulmonary clearance of free radical loaded white blood cells and platelets is an important contributor to enhanced oxidative stress in congestive heart failure patients. Failure of pulmonary clearance of free radical loaded white blood cells and platelets probably results from pulmonary congestion which has led to the rationale of the current study. Biventricular pacing for resynchronization therapy in congestive heart failure patients reduces left ventricular filling pressure and pulmonary congestion. Biventricular pacing may therefore augment pulmonary clearance of free radical loaded white blood cells and platelets in congestive heart failure patients.
We conduct a prospective, observational clinical study to investigate the correlation of left ventricular filling pressure, pulmonary clearance of FR loaded circulating white blood cells and platelets and number of endothelial progenitor cells in congestive heart failure (CHF) patients before and after implantation of a biventricular pacemaker for resynchronization therapy.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| CHF | Informed consented participants are recruited among all patients admitted to the OLVG hospital. Inclusion criteria:
Exclusion criteria:
| ||
| Control | The control group consists of ten age-matched volunteers with a normal left ventricular ejection fraction and without signs or symptoms of heart failure. |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| • Number of (apoptotic) endothelial (progenitor) cells | baseline |
| Measure | Description | Time Frame |
|---|---|---|
| • Oxidative stress: cytosolic and mitochondrial FR | baseline |
Not provided
Patient selection
Informed consented participants are recruited among all patients admitted to the OLVG hospital.
Inclusion criteria:
Exclusion criteria:
Not provided
Not provided
Not provided
Not provided
Patients admitted to the OLVG hospital for worsening congestive heart failure selected for biventricular pacemaker implantation
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Walter J Paulus, Professor | Contact | 00 31 20 444 8110 | wj.paulus@vumc.nl | |
| Alexander J IJsselmuiden, MD, PhD | Contact | 00 31 20 444 8110 | ijsselmuiden@vumc.nl |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| OLVG Hospital | Amsterdam | North Holland | 1090hm | Netherlands |
Not provided
| Label | URL |
|---|---|
| United Committee Human Research (the Netherlands) | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Bloodsamples
| ID | Term |
|---|---|
| D006333 | Heart Failure |
| ID | Term |
|---|---|
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
Not provided
Not provided